- Home
- CNXC vs SRRK Comparison
CNXC vs SRRK Comparison
Compare CNXC & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNXC
- SRRK
- Stock Information
- Founded
- CNXC 1991
- SRRK 2012
- Country
- CNXC United States
- SRRK United States
- Employees
- CNXC N/A
- SRRK N/A
- Industry
- CNXC Computer Software: Prepackaged Software
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNXC Technology
- SRRK Health Care
- Exchange
- CNXC Nasdaq
- SRRK Nasdaq
- Market Cap
- CNXC 3.6B
- SRRK 3.0B
- IPO Year
- CNXC N/A
- SRRK 2018
- Fundamental
- Price
- CNXC $47.94
- SRRK $40.61
- Analyst Decision
- CNXC Strong Buy
- SRRK Strong Buy
- Analyst Count
- CNXC 5
- SRRK 9
- Target Price
- CNXC $69.00
- SRRK $45.25
- AVG Volume (30 Days)
- CNXC 1.1M
- SRRK 2.7M
- Earning Date
- CNXC 09-25-2025
- SRRK 11-11-2025
- Dividend Yield
- CNXC 3.00%
- SRRK N/A
- EPS Growth
- CNXC 54.10
- SRRK N/A
- EPS
- CNXC 4.74
- SRRK N/A
- Revenue
- CNXC $9,720,870,000.00
- SRRK N/A
- Revenue This Year
- CNXC $3.62
- SRRK N/A
- Revenue Next Year
- CNXC $3.16
- SRRK $1,996.18
- P/E Ratio
- CNXC $10.13
- SRRK N/A
- Revenue Growth
- CNXC 3.40
- SRRK N/A
- 52 Week Low
- CNXC $36.28
- SRRK $22.71
- 52 Week High
- CNXC $66.00
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- CNXC 41.04
- SRRK 65.45
- Support Level
- CNXC $46.47
- SRRK $37.80
- Resistance Level
- CNXC $49.37
- SRRK $43.48
- Average True Range (ATR)
- CNXC 2.23
- SRRK 2.91
- MACD
- CNXC -0.45
- SRRK 0.59
- Stochastic Oscillator
- CNXC 36.64
- SRRK 79.99
About CNXC Concentrix Corporation
Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from Philippines.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.